Kelis Gola (Ketoprofen Lysine)

Ketoprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever at the site of injury.

The specific dose of Kelis Gola is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ketoprofen is generally not recommended during pregnancy, especially in the third trimester, due to potential risks to the fetus. It is also excreted in breast milk, so use while breastfeeding should be discussed with a qualified healthcare provider.

To request Kelis Gola, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kelis Gola (ketoprofen) offers potent anti‑inflammatory and analgesic effects similar to ibuprofen and naproxen, but it may have a slightly higher risk of gastrointestinal irritation. Choice of NSAID depends on individual patient factors, tolerability, and the prescribing clinician’s assessment.

Kelis Gola should be stored at ambient temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and excessive heat to maintain product stability.

Kelis Gola is intended for oromucosal administration. The tablet or formulation is placed in the mouth and allowed to dissolve, ensuring direct absorption through the oral mucosa as directed by the prescriber.

Serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, significant renal impairment, and cardiovascular events like myocardial infarction. Patients should be monitored for these adverse events, especially with long‑term use.

Kelis Gola should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal ulcers, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. Clinicians should evaluate each patient’s medical history before prescribing.